Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 386.75 billion. The enterprise value is 397.46 billion.
| Market Cap | 386.75B |
| Enterprise Value | 397.46B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | Aug 5, 2025 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 253.70M |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -6.00% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 47.32% |
| Float | 139.31M |
Valuation Ratios
The trailing PE ratio is 33.89 and the forward PE ratio is 27.32. NSE:IPCALAB's PEG ratio is 1.13.
| PE Ratio | 33.89 |
| Forward PE | 27.32 |
| PS Ratio | 3.94 |
| PB Ratio | 4.06 |
| P/TBV Ratio | 4.92 |
| P/FCF Ratio | 79.57 |
| P/OCF Ratio | 33.87 |
| PEG Ratio | 1.13 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.53, with an EV/FCF ratio of 81.78.
| EV / Earnings | 34.83 |
| EV / Sales | 4.05 |
| EV / EBITDA | 18.53 |
| EV / EBIT | 23.01 |
| EV / FCF | 81.78 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.76 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.38 |
| Debt / FCF | 1.66 |
| Interest Coverage | 22.85 |
Financial Efficiency
Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 14.56%.
| Return on Equity (ROE) | 13.22% |
| Return on Assets (ROA) | 8.99% |
| Return on Invested Capital (ROIC) | 14.56% |
| Return on Capital Employed (ROCE) | 17.24% |
| Weighted Average Cost of Capital (WACC) | 4.70% |
| Revenue Per Employee | 5.85M |
| Profits Per Employee | 680,129 |
| Employee Count | 16,778 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.07 |
Taxes
In the past 12 months, NSE:IPCALAB has paid 3.81 billion in taxes.
| Income Tax | 3.81B |
| Effective Tax Rate | 24.36% |
Stock Price Statistics
The stock price has increased by +1.98% in the last 52 weeks. The beta is 0.07, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | +1.98% |
| 50-Day Moving Average | 1,536.54 |
| 200-Day Moving Average | 1,438.70 |
| Relative Strength Index (RSI) | 42.81 |
| Average Volume (20 Days) | 349,008 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 98.21 billion and earned 11.41 billion in profits. Earnings per share was 44.98.
| Revenue | 98.21B |
| Gross Profit | 69.98B |
| Operating Income | 17.35B |
| Pretax Income | 15.65B |
| Net Income | 11.41B |
| EBITDA | 21.53B |
| EBIT | 17.35B |
| Earnings Per Share (EPS) | 44.98 |
Balance Sheet
The company has 11.98 billion in cash and 8.09 billion in debt, with a net cash position of 3.89 billion or 15.34 per share.
| Cash & Cash Equivalents | 11.98B |
| Total Debt | 8.09B |
| Net Cash | 3.89B |
| Net Cash Per Share | 15.34 |
| Equity (Book Value) | 95.24B |
| Book Value Per Share | 317.89 |
| Working Capital | 40.70B |
Cash Flow
In the last 12 months, operating cash flow was 11.42 billion and capital expenditures -6.56 billion, giving a free cash flow of 4.86 billion.
| Operating Cash Flow | 11.42B |
| Capital Expenditures | -6.56B |
| Depreciation & Amortization | 4.18B |
| Net Borrowing | -6.20B |
| Free Cash Flow | 4.86B |
| FCF Per Share | 19.16 |
Margins
Gross margin is 71.26%, with operating and profit margins of 17.67% and 11.62%.
| Gross Margin | 71.26% |
| Operating Margin | 17.67% |
| Pretax Margin | 15.93% |
| Profit Margin | 11.62% |
| EBITDA Margin | 21.92% |
| EBIT Margin | 17.67% |
| FCF Margin | 4.95% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.59% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.27% |
| Earnings Yield | 2.95% |
| FCF Yield | 1.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:IPCALAB is 1,676.82, which is 10.00% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,676.82 |
| Price Target Difference | 10.00% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |